Document V32XgKQYx01vz7xova4xKmwyw

Benzene Health Research Consortium 4004 Financial Report Overview Case Diagnosis: JCML clinical lab continues to increase diagnostic throughput, operating well above 100% capacity, processing 30% more cases than anticipated with 99+% concordance between primary diagnosis & Case Accrual: Cases are being accrued at optimal rate from all participating hospitals, with 500+ AML and External Review Panels: Panels reviewing progress reports, manuscripts and presentations as these Fund Balance at API 4Q04: $2,823, 1691 Irons Field Expenses: New T&E contract executed in 4004. Total T&E expenses remain slightly ($14K) UCHSC: Contract amendment executed with UCHSC; $874,030 additional was disbursed 4004, for a total Subcontracts: 4004 subcontractor expenses include Fudan Univ ($880K) and Children's Hosp ($68K); no AHS: Travel expenses have stayed under budget, but high labor costs due to time spent in Shanghai have Fudan University: Additional case load, and transfer of CDC & IPHS activities has increased rate of SRP/ERP: Total expenses remain under budget as of year end 2004. Consortium should consider Communications (APCO): program budget reduced to $300K ($250K to contingency) Outside Legal Council: cummulative variance of 20% over budget QAlQC: program budget reduced to $50K ($50K to contgency) Contingency: increased by $300K ($250K from communicaitons; $50K from OA/OC). API Administrative Costs: essentially on budget. (J) I m r SRP/ERP projected expenses need to be re-analyzed to reflect new meeting venue and possibly reduced r sI : () () r C ;a G) oI c..n Page 1 of 57 -.....J c..n c..> c..n AUTO DATE Benzene Health Research Consortium 4004 Financial Report Overview UCHSC grant requires close monitoring due to large 2004 expenses and new casebased cost structure Irons Field Expenses: new T&E contract in place. Fudan University: new contract should be executed in 1004. API administrative expenses requires close monitoring to contain costs. Projected expenses for 2005 will Need to reconcile UCHSC statement - they have a $105 error (from 4003 rpt). Technical Budget Work Group Acceptance: April 08,2005 (pending) Oversight Committee Acceptance: Posted to Website: LT 2/14/05 BJ 4/04/05 (J) I m r r sI : () () r C ;a G) oI c..n Page 2 of 57 -.....J c..n c..> (J) AUTO DATE Item AHScienc es CaseControl Study DP&ME Studies (UCHSC) Irons(T & E) Fudan University Total Research Costs Scientific Review Panel Ethics Review Panel Benzene Health Research Consortium Approved Program Budget Approved Original Cost Revised Cost 4Q04 Financial R- ......... Unapproved Approved Changes not Approved Approved Estimate Estimate approved (June 11 NOV 03 OC 21 APR 04 OC 16 Dec 04 OC (Jan. 2001) (Dec. 2001) 2003) mtg mtg mtg $1,595,000 $2,283,095 $2,283,095 $2,283,095 $2,283,095 $2,283,095 $13,665,017 $15,258,017 $1,253,428 $1,253,428 $165,700 $190,555 $16,679,145 $18,985,095 $15,258,000 $1,597,273 $661,000 $19,799,368 $14,508,000 $1,413,428 $230,000 $18,434,523 $14,508,000 $14,508,000 $1,413,428 $1,413,428 $230,000 $230,000 $18,434,523 $18,434,523 $648,000 $551,736 $300,000 $300,000 $300,000 $216,000 $192,000 $64,000 $64,000 $64,000 External Pathology & Cytogenet ics Workgrou (J) ps(Cost in I UC cost) m r Total Panel Costs r API Seed s:I Monies () Outside () r Counsel C ;a G) oI c..n c-......n.J c..> -.....J $450,000 $500,000 $130,000 $994,000 $0 $500,000 $0 $743,736 $0 $100,576 $0 $364,000 $0 $100,000 $0 $364,000 $0 $100,000 $0 $364,000 $0 $100,000 Page 3 of 57 AUTO DATE Public Affairs QAlQC Activities UCHSC Interest contingency Miscellaneous Costs Subtotal API Admin. GRAND TOTAL Benzene Health Research Consortium Approved Program Budget 4Q04 Financial Report $1,000,000 $1,000,000 $960,600 $550,000 $550,000 $300,000 $225,000 $190,855 $1,690,855 $18,820,000 $941,000 $0 $1,725,000 $21,704,095 $1,085,205 $100,000 $0 $1,161,176 $21,704,280 $1,085,019 $100,000 ($100,000) $390,272 $1,040,272 $19,838,795 $1,245,205 $100,000 $0 $290,272 $1,040,272 $19,838,795 $1,245,205 $50,000 $0 $590,272 $1,040,272 $19,838,795 $1,245,205 $19,761,000 $22,789,300 $22,789,299 $21,084,000 $21,084,000 $21,084,000 Notes by API Notes/As sumption s for Dec. 2001 revised budget: - The total research costs have changed as a result of - Panel costs assume that there will be only one face-to- face meeting for each panel each year. LT 1/28/05 (J) I m r r sI : () () r C ;a G) oI c..n Page 4 of 57 -.....J c..n c..> ex> AUTO DATE Benzene Health Research Consortium Executive Summary 4Q04 Financial Report Cost Centers Income Project # Inception Thru December 2003 Actuals Actuals Jan - Dec 2004 $ 15,257,275 $ 1,508,419 $ 16,765,693 Cost Centers UCHSC* Irons-Field Expense* Applied Health Sciences Fudan University X8105 X8106 X8107 X8108 Scientific & Ethics Panels Communications Outside Legal Counsel QAlQC Support API Administrative Contingency** X8109 X8103 X8104 X8110 X8100 Total Expenses Fund Balance 7,515,759 539,486 951,892 31,981 2,622,091 249,000 439,122 92,109 10,137,850 788,486 1,391,014 124,090 82,854 290,866 33,208 83,917 3,295 31,322 166,772 294,161 64,529 594,670 101,473 276,480 3,000 871,150 104,473 $ 10,142,189 $ 3,800,336 $ 13,942,525 $ 5,115,086 $ (2,291 ,917)~g~~~~lR! Cumulative Actuals Inception Thru 4Q04 Budget (actual + projected income 2005 2006 $ 16,765,693 $ 1,826,667 *** $ 1,278,667 10,137,850 788,486 1,391,014 124,090 166,772 294,161 64,529 871,150 104,473 $ 13,942,525 1,748,060 262,000 441,867 29,148 1,748,060 262,000 449,985 29,148 76,000 1,946 16,698 16,667 123,330 162,933 71,000 1,946 16,698 16,667 123,200 162,933 $ 2,878,649 $ 2,881,637 :::::Irn:rvlln?r::: :::::::::r:::::::::::::::::::~U~~MnZ::::::::::::::: (J) I ::~!:9@:::!!::~MqJ.~~:::~:9Q~:::!I!~QGI!:::~g::::::::::::iii:::::: m * amount disbursed by API r r s:I ** $300K added to contingency; () $250K from Communicaitons & $50K () from QAlQC r C ;a G) oI c..n -.....J c..n c..> <D Page 5 of 57 AUTO DATE & expenses) 2007 Projected Expenses Program Budget $1,278,667 $ 21,149,694 1$ 21,084,000 1 Benzene Health Research Consortium Executive Summary 4Q04 Financial Report 874,030 104,714 45,833 29,148 14,508,000 1,417,200 2,328,699 211,534 14,508,000 1,413,428 2,283,095 230,000 44,000 1,946 16,698 16,667 123,200 159,933 357,772 300,000 114,623 50,000 1,240,880 590,272 364,000 300,000 100,000 50,000 1,245,205 590,272 $1,416,169 $ 21,118,980 1$ 21,084,000 1 :i:i:i:i:i:i:i:i:i:i:i:i:iI19filii: (J) I m r r Income s:I Detail () sponsors $16,500,000 () 2001 seed $15,000 r C ;a G) oI c..n c-......n.J ..j:::o. o Page 6 of 57 AUTODATE *** ConocoPhillips pay remaining commitment in 2005 LT 2/14/05 Benzene Health Research Consortium Executive Summary 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 7 of 57 AUTODATE c-......n.J ..j:::o. .....lo. MAP contrib. API interest UCHSC interest TOTAL $200,000 $50,692 $0 $16,765,692 Benzene Health Research Consortium Executive Summary 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 8 of 57 AUTO DATE c-......n.J ..j:::o. I'V Benzene Health Research Consortium Case Accrual 4Q04 (+) Variance: above predicte rate of accrual, (-) Variance: below predicted rate of accrual. Gase predictions based on historical estimates; these are not target numbers of cases required for study completion. LT 8/30/04 BJ 3/30/05 (J) I m r r sI : () () r C ;a G) ocI.n c-.....n.J ..j:::o. c..> AUTODATE Benzene Health Research Consortium Case Accrual 4Q04 (J) I m r r sI : () () r C ;a G) oI c..n AUTODATE c-......n.J ..j:::o. ..j:::o. Benzene Health Research Consortium Cash Flow Statement 4Q04 Financial Report :f!gM,e~r~!iM!WM~~:rrrr }r.@!c!j'.::%!'!'W'<l.l.~!,!::::::::::::::::::' LT 10/18/04 NOTE,! $4J$~,4$$lin bank at API (J) I m r r sI : () () r C ;a G) ocI.n 11 of 57 AUTODATE c-.....n.J .,j:::o. c.n Benzene Health Research Consortium Cash Flow Statement 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n 12 of 57 AUTODATE c-......n.J ..j:::o. (J) Cost Centers Benzene Health Research Consortium Program Expense Summary 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J ..j:::o. -.....J Benzene Health Research Consortium Program Expense Summary 4Q04 Financial Report r-------------~----~~----------~~------------~--~~~~, Cost Centers (J) I m r r sI : () () r C ;a G) oI c..n -.....J c..n ..j:::o. Page 14 of 57 AUTODATE ex> Benzene Health Research Consortium Program Expense Summary 4Q04 Financial Report LT 10/18/04 Amt.At UCHSC & Irons Field exp. Bank acct $12,603,965 $11,400,949 expense reporting for $1,175,224 3004) $27,044 In Irons' field exp bank acct as of 6/30104 (3004 exp report outstanding) $1,203,016 Total as of $1 ,202,268 6/30104 API disbursed by period (includes pre-payments for UCHSC & Irons Field) 24,600 1,577,811 7,652,678 318,759 258,097 310,244 66,019 1,348,626 1,047,131 1,338,560 131,000 874,030 131,000 874,030 131,000 874,030 131,000 (J) I m r r sI : () () r C ;a G) ocI.n c.n-.....J .,j:::o. Page 15 of 57 AUTODATE <D Benzene Health Research Consortium Program Expense Summary 4Q04 Financial Report r-------------~----~~----------~~------------~--~~~~, Cost Centers LT 10/18/04 API disbursed by period 874,030 104,714 874,030 IT IT 18,916,789 (includes pre-payments for UCHSC & Irons Field) (J) I m r r sI : () () r C ;a G) ocI.n cc-......nn.J Page 16 of 57 o AUTODATE Benzene Health Research Consortium UCHSC Grant 4Q04 Financial Report (J) I m r UCHSC r statement s:I error for travel, off by +$105 () (4Q03) () r C ;a G) oI c..n c-......n.J Page 17 of 57 AUTODATE c..n .....lo. Benzene Health Research Consortium UCHSC Grant 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 18 of 57 AUTODATE c..n I'V Cost Centers LT 3/11/05 BJ 1/03/05 (J) I m r r sI : () () r C ;a G) ocI.n cc-......nn.J c..> Am!. paid UCHSCto date: Am!. expensed to date: Am!. In UCHSC bank acct: Benzene Health Research Consortium UCHSC Grant 4Q04 Financial Report 3rd Otr 4th Otr (Adjusted 4003: $48,839 attributed to UCHSC in 3003 Report has been reallocated to Contingency: $25,000 preconsortium gran tin 2001; $3,600 for IRB Review in 2002; $20,239 for EMBSI "feasibility $9,263,820 study" in 2002) (Adjusted 4003: 2001 costs had been double expensed in 2002 column; ($523,807) adjusment $8,088,596 made in 4003) $1,175,224 Page 19 of 57 1st Otr 2nd Otr 3rd Otr 4th Otr AUTODATE UCHSC (x81 05) Cost Centers Benzene Health Research Consortium UCHSC Grant 4Q04 Financial Report 2006 2nd Olr. 3r.d Olr. 4lh Olr. 2007 2nd Olr. 3r.d Olr. 4lh Olr. LT 3/11/05 BJ 1/03/05 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J c..n ..j:::o. Page 20 of 57 AUTODATE Benzene Health Research Consortium UCHSC Subcontract 4Q04 Financial Report LT 8/6/04 BJ 1/03/05 "Total subcontracto r expenses" from study report (preliminary figure); "actual expenses" from UC Office of Grants & Contracts spreadsheet (final figures). (J) I m r r sI : () () r C ;a G) oI c..n -.....J c..n c..n c..n Page 21 of 57 AUTODATE Cost Centers 1st & 2nd Benzene Health Research Consortium Irons Field Expenses 4Q04 Financial Report 4Q03 ADJUSTME NT2001/2002 expense underrecord ed; -0$114,289 adjustment (J) I m r r sI : () () r Amt paid to C Irons to numbers as ;a date $788,486 of 12131/04 Amt Irons G) has spent $761,442 oI c..n -.....J c..n Page 22 of 57 c..n (J) AUTODATE Cost Centers 2nd Olr. 3r.d Olr. 4lh Olr. Benzene Health Research Consortium Irons Field Expenses 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 23 of 57 AUTODATE c..n -.....J LT 2114/05 BJ 1/25/05 Amt. In Irons bank acct: $27,044 Benzene Health Research Consortium Irons Field Expenses 4Q04 Financial Report 15tOtr. 2nd Otr. 15tOtr. 2nd Otr. 3rd Otr. 4th Otr. 15tOtr. 2nd Otr. 3rd Otr. 4th Otr. 15tOtr. (J) I m r r sI : () () r C ;a G) ocI.n cc-......nn.J Page 24 of 57 AUTODATE ex> IRONS T&E (X81 06) Cost Centers LT 2114/05 BJ 1/25/05 2007 2nd OIL 3rd OIL 4lh OIL Benzene Health Research Consortium Irons Field Expenses 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 25 of 57 AUTODATE c..n <D Cost Centers 1st & 2nd Benzene Health Research Consortium AHS 4Q04 Financial Report LT 10/18/04 BJ 1/25/05 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J (J) o Adjustment: expense reduced by $52,634; transferred to contingency since these were preconsortia expenses Page 26 of 57 AUTODATE Cost Centers 2nd Ole. 3rd Ole. 4lh Ole. Benzene Health Research Consortium AHS 4Q04 Financial Report LT 10/18/04 BJ 1/25/05 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J (J) .....lo. Page 27 of 57 AUTODATE Benzene Health Research Consortium Fudan 4Q04 Financial Report LT 10/20104 BJ 1/25/05 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J (J) I'V Page 28 of 57 AUTODATE Benzene Health Research Consortium Fudan 4Q04 Financial Report LT 10/20104 BJ 1/25/05 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J (J) c..> Page 29 of 57 AUTODATE Benzene Health Research Consortium (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J (J) ..j:::o. Benzene Health Research Consortium SRP + ERP 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n -.....J c..n (J) Page 31 of 57 AUTODATE c..n Benzene Health Research Consortium . . .:~i#.ri\MM~#li~~:#'ii~~W~WW~:iii@:@iiii:iiiH~\#'@?(::::::::::.: LT 10/20104 BJ 2/04105 1Q04 budget ajustments to zero our variance to develop more useful budget projections for remainder of program. Change approved by OC at 4/21/04 meeting. (J) I m r r sI : () () r C ;a G) oI c..n -.....J c..n(J) Page 32 of 57 (J) AUTODATE Benzene Health Research Consortium SRP + ERP 4Q04 Financial Report :~i#,:jii~i:~:@W~:#'ii~~@~:~~~:W~ LT 10/20104 BJ 2/04105 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J (J) -.....J Page 33 of 57 AUTODATE Cost Centers Benzene Health Research Consortium Communications 4Q04 Financial Report (J) I m r r s:I Duplicating/Copies Internal, Postage, Couriers, ( ) Telephone, Meals, Lexis Nexis Searches . . . . .( ) ::~!MMf!lBm::EWM1!lW~W@WWfM~mm@mr~:?:r::r::r::r::r::r:r::::::::::::::::::::::::.:.: r .......Mj~iH;:~~:~f:i.!&i@~}}}}}}}}}}}}}}}}}}}}}}))::::::::::::::: . C "~BLJdgetadjustrr1erltiefiedsbLJdgetiedLJc;ti()rl ;a frorn $1 MM to $550k G) oI c..n LT 1/28/05 RT 1/21/05 c-......n.J (J) ex> Duage! aaJuslrnem lO lower prograrn budget frorn $550K to Page 34 of 57 AUTODATE Cost Centers Benzene Health Research Consortium Communications 4Q04 Financial Report (J) I m r r s:I Duplicating/Copies Internal, Postage, Couriers, ( ) Telephone, Meals, Lexis Nexis Searches () ::~!MMf!lBm::EWM1!lW~W@WWfM~mm@mr~:?: r Mj~iH;:~))i!!ifiii.f:i.!&i@{((((((((((((((((((((((:) C "~BLJdgetadjustrr1erltiefiedsbLJdgetiedLJc;ti()rl ;a frorn $1 MM to $550k G) oI c..n LT 1/28/05 RT 1/21/05 c-......n.J (J) <D Page 35 of 57 AUTODATE Cost Centers 12116/04 Benzene Health Research Consortium Communications 4Q04 Financial Report 1s1 & 2nd 1sl Olr. 2nd Olr. 3rd Olr. 4lh Olr. 1s101r. (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 36 of 57 AUTODATE o-.....J Cost Centers Benzene Health Research Consortium Communications 4Q04 Financial Report 2006 2nd Olr. 3rd Olr. 4lh Olr. 2 I 1sl Olr. 2007 2nd Olr. 3rd Olr. 4lh Olr. (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 37 of 57 AUTODATE -.....J .....lo. * budget adjustment to lower program budget from $500K to $1 OOK, as approved by OC on 11 III 103 LT 7/19/04 RT 1/21/05 Benzene Health Research Consortium Legal 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) ocI.n c-.....n.J Page 38 of 57 AUTODATE -.....J I'V * budget adjustment to lower program budget from $500K to $1 OOK, as approved by OC on 11 III 103 LT 7/19/04 RT 1/21/05 Benzene Health Research Consortium Legal 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) ocI.n c-.....n.J Page 39 of 57 AUTODATE -.....J c..> Benzene Health Research Consortium QA-QC 4Q04 Financial Report (J) I m r r sI : () () r budget adjustment to lower C program budget from $225K to ; a $100K, as approved by OC on G) 11/11/03 oI LT 1128105 c..n c-......n.J -.....J ..j:::o. Page 40 of 57 AUTODATE Benzene Health Research Consortium QA-QC 4Q04 Financial Report (J) I m r r sI : () () r budget adjustment to lower C program budget from $225K to ; a $100K, as approved by OC on G) 11/11/03 oI LT 1128105 c..n c-......n.J c-......n.J Page 41 of 57 AUTODATE Cost Centers Benzene Health Research Consortium API Administration 4Q04 Financial Report (J) I m r r s:I LT7/19/04 ( ) RT 1/21/05 () r Assumptions: C ;a Year 5, 6,7 Less than 1 FTE allocated, G) based allocated cost on 112 FTE oI c..n T&E and Other $15K for Annual Meeting (3rd Quarter) c-......n.J -.....J (J) Page 42 of 57 AUTODATE Cost Centers Benzene Health Research Consortium API Administration 4Q04 Financial Report (J) I m r r s:I LT7/19/04 ( ) RT 1/21/05 () r Assumptions: C ;a Year 5, 6,7 Less than 1 FTE allocated, G) based allocated cost on 112 FTE oI c..n T&E and Other $15K for Annual Meeting (3rd Quarter) c-......n.J -.....J -.....J Page 43 of 57 AUTODATE funds for consultant Benzene Health Research Consortium API Administration 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 44 of 57 AUTODATE -.....J ex> 2006 2nd Olr. 3rd Olr. Benzene Health Research Consortium API Administration 4Q04 Financial Report 4lh Olr. 1s101r. 2007 2nd Olr. 3rd Olr. 4lh Olr. (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 45 of 57 AUTODATE -.....J <D Benzene Health Research Consortium Contingency Fund 4Q04 Financial Report (J) I m r r sI : () LT 214/05 () r C ;a G) oI c..n -.....J c..n ex> o 4Q03 Adjustment - per Technical Committee, transfer $48,839 from UCHSC expense detail to contingency because expenses not part of UCHSC grant budget: Page 46 of 57 AUTODATE Benzene Health Research Consortium Contingency Fund 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 47 of 57 AUTODATE -.....J c..n ex> .....lo. TOTALS $590,272 $0 $0 $590,272 $0 $48,839 $0 ($48,839) $0 $52,634 $0 ($52,634) $0 $3,000 $0 ($3,000) $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 .:.:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: .$59(),272.()() $104,473.00 $0.00 (J) $485,799.00 I m r $0.00 r $0.00 sI : () () r C ;a G) oI c..n -.....J c..n ex> I'V Benzene Health Research Consortium Contingency Fund 4Q04 Financial Report Page 48 of 57 AUTODATE Benzene Health Research Consortium Contingency Fund 4Q04 Financial Report J-\n0 - t:Xpt:II:::;t;:: lIdll:::;It:1 VI $52,634 from AHS expense detail to contingency because expenses not part of AHS full study budget I . ..JUlIt: c..uu I ..j)LJr\. YId.lll LV UCHSC; seed money exhausted (API & sponsor), expense not included in final grant cost estimate L. ".50UU ltil:) Tees IO U or lJU (this will be a yearly fee, since IRB must review at least once per year) j. LUUL inVOice (~LU,Lj8) trom EMBSI for final feasibility study work (very late billing to API) (J) I m r r sI : () () r C ;a G) oI c..n Page 49 of 57 AUTODATE -.....J c..n ex> c..> LT 7/19/04 RT 1/21/05 (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J ex> ..j:::o. Benzene Health Research Consortium Income 4Q04 Financial Reoort Page 50 of 57 AUTODATE Benzene Health Research Consortium Income 4Q04 Financial Reoort (J) I m r r sI : () () r C ;a G) oI c..n Page 51 of 57 AUTODATE -.....J c..n ex> c..n Company Name BP Gnevron I exaco ConocoPhillips ExxonMobii Shell Marathon lotal (Seed Money) Inv, # Date Paid $15,000 $22,500 ~l:',UUU 522922 528453 :'1181::1 8-Nov-00 19-Jun-01 (-NOV-UU $15,000 522924 31-0ct-00 $7,500 528574 31-Jul-01 $0 523540 $15,000 523054 24-0ct-00 $15,000 528333 15-May-01 $15,000 528541 14-Aug-01 :;120,000 Benzene Health Research Consortium Sponsor Invoice Detail 4Q04 Financial Report 2001 2002 (1 st - 2nd Qtr,) 2002 (3rd - 4th Qtr,) 22-Aug-01 Inv, # Date Paid $768,941 529301 4-0ct-01 ~:'LL,(jL{ :'L8::1UL 8-Uct-Ul $246,314 529309 17-Sep-01 9-Jan-02 Inv,# Date Paid 27-Aug-02 Inv, # Date Paid $806,441 ~:'::I{,(jL{ 532263 :'::11144 22-Feb-02 LL-t-eb-UL $1,344,069 $112,008 ~tl8(j,U4(j 535033 :,::I:,U::I4 11-0ct-02 2-0ct-02 :,-NOV-UL $268,814 532245 16-Jan-02 $448,023 535035 26-Sep-02 $507,627 529305 25-Sep-01 $1,612,882 532246 $806,441 $806,441 $537,627 532247 23-Jan-02 11-Feb-02 7-Feb-02 $1,344,069 $896,046 $448,023 $448,023 535036 535037 13-Sep-02 25-Sep-02 10-Feb-03 :;2,045,509 :;5,376,273 Marathon Ashland Marathon Oil :;5,936,307 2003 23-Sep-03 Inv,# Date Paid $1,431,041.00 544951 4-0ec-03 ~1 ,ULtl,lUU.UU :'448:'::1 18-NOV-U::I $514,349.00 544954 27-0ct-03 $1,543,049.00 544956 $771 ,524.50 $771 ,524.50 $1,028,700.00 544958 $514,350 $514,350 $150,000 548582 $50,000 548581 :;8,317,588,00 3-0ct-03 22-Mar-04 28 Oct 03 14 Jan 04 20-Jan-04 3-Feb-04 LT 7/19/04 (J) I m r r sI : () () r C ;a G) oI c..n -.....J Page 52 of 57 AUTODATE c..n ex> (J) Benzene Health Research Consortium Sponsor Invoice Detail 4Q04 Financial Report TOTAL $4,500,000 $4,500,000 $3,000,000 $215,000 (J) I m r r sI : () () r C ;a G) oI c..n -.....J Page 53 of 57 AUTODATE c..n ex> -.....J Benzene Health Research Consortium Sponsor Payment Detail 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) RT oI 5/5/04 c..n -.....J c..n ex> ex> 3Q03 $- (note - does not include interst income) Page 54 of 57 AUTODATE LT 7/19/0 4 Benzene Health Research Consortium Sponsor Payment Detail 4Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n c-......n.J Page 55 of 57 AUTODATE ex> <D Company Date Paid Amount American Petroleum Institute 1/17/2003 $ (I am trying to get this $1.09 1.09 I emoved from the books) BP International Limited 11/8/2000 $ 15,000.00 BP International Ltd 6/19/2001 $ 22,500.00 BP p.Lc. 10/4/2001 $ 768,941.00 BP p.Lc. 2/22/2002 $ 806,441.00 BP p.Lc. BP p.Lc. BP p.Lc. 10/2/2002 $ 112,008.00 10/11/2002 $ 1,344,069.00 12/4/2003 $ 1,431,041.00 $ BP Total 4,500,000.00 Chev ronTexaco Chev ronTexaco Chev ronTexaco Chev ronTexaco Chev ronTexaco 11/7/2000 $ 10/9/2001 $ 2/22/2002 $ 11/5/2002 $ 11/19/2003 $ 15,000.00 522,627.00 537,627.00 896,046.00 1,028,700.00 ChevronTexaco Total $ 3,000,000.00 ConocoPhillips 10/31/2000 $ 15,000.00 ConocoPhillips 7/31/2001 $ 7,500.00 ConocoPhillips 9/17/2001 $ 246,314.00 ConocoPhillips 1/16/2002 $ 268,814.00 ConocoPhillips ConocoPhillips 9/26/2002 $ 448,023.00 ConocoPhillips Total 10/27/2003 $ 514,349.00 $ 1,500,000.00 ExxonMobil Research and Engineering 1/23/2002 $ 806,441.00 ExxonMobil Research and Engineering ExxonMobil 2/11/2002 $ 806,441.00 9/13/2002 $ 1,344,069.00 ExxonMobil ExxonMobil 10/3/2003 $ 771,524.50 3/22/2004 $ 771,524.50 $ ExxonMobil Total 4,500,000.00 Marathon Ashland Petroleum, LLC. 8/14/2001 $ 15,000.00 Marathon Ashland Petroleum, LLC. Marathon Oil Company 1/20/2004 $ 150,000.00 Marathon Ashland Total 2/3/2004 $ 50,000.00 $ 215,000.00 Shell Chem ical (J) I Shell Chem ical m Shell Chem ical r r Shell Chem ical s:I Shell Chem ical () Shell Chem ical () Shell Chem ical r C Shell Chem ical ;a G) oI c..n c-......n.J <D o 10/24/2000 $ 5/15/2001 $ 9/25/2001 $ 2/7/2002 $ 9/25/2002 $ 2/10/2003 $ 10/28/2003 $ 1/13/2004 $ 15,000.00 15,000.00 507,627.00 537,627.00 448,023.00 448,023.00 514,350.00 514,350.00 Shell Chem ical Total $ 3,000,000.00 o0') SHELL-MCCLURG-057591 t-uaan university tsuaget lAprll LUU::') Red: revisions for new Fudan contract (using $159,531 remaining OCBlue: Fudan budget reanalysis, through 2Q 2007 Labor (time) CategoCi Physician epidemiologist Data Handler Total labor (US$) Expenses Fudan University -- Budget for Case Control Study (2004 - 2006) Annual Salary* 2004 (Year 4) US~ Time Amount 16,900 0.15 2,535 5,850 1.00 5,850 8,385 2005 (Year 5) Time Amount 0.15 2,535 1.2 tOO 5G 8-;-385 9,504 2006 (Year 6) Time Amount 0.25 4,225 1.16 tOO 5G l-G,-W5 11,022 Unit cost No. Amount No. Amount No. Amount Total 9,295 Hz5W ~ 28,911 Total Fee for Shanghai CDC staff Fee for AM L patients Fee for NHL patients Hospital coordinators Fee for controls Fee for NHL hospital coordination Fee for office supplies I ransportatlon fOr local and long distance Total expenses (US$) 6,000 0 197 0 30 93 2,790 30 93 2,790 30 580 17,400 5,000 1,800 1,200 36,980 6,000 150 4,500 150 4,500 150 4,500 600 18,000 5,000 1,800 1,200 45,500 3,000 130 3,900 130 3,900 130 3,900 430 12,900 5,000 1,700 1,200 35,500 15,000 8,400 11,190 11,190 48,300 15,000 5,300 117,980 Sub Total (US$) Overhead Fee (15%) 45,365 6,805 53-;-885 8-;--H-5 50,504 45-;-5-75- 42,622 111,825 7,576 7,354- 6,393 N;-874 Grand Total Requested (US$) 52,170 62,600 52,929 167,699 (J) Revised to $159,531 I remaining approved funds: m r r Add transport for annual s:I mtgs () Add 5% annual increase () Add shortfall cr Total: ;a G) I 0c..n c-......n.J <D I'V 52,170 12,000 3,209 0 15,209 58,356 12,000 3,518 4,244 19,762 49,015 12,000 3,051 3,914 18,965 159,531 36,000 9,778 8,168 53,946 1IIIIIIIIIIIIIIIIIIIi;~11 ~~:/::;r SH ELL-MCCLU RG-OS7S93 To: tc@listserve.api.org> From: Cc: Bcc: Received Date: Subject: Bruce Jarnot <j arnotb@api.org>; benzconsort-tc@ listserve. api. org <benzconsort- Bruce Jarnot <jarnotb@api.org> Lorraine Twerdok <Twerdokl@api.org> 2005-04-0619:14:18 GMT SHS... 2nd FYI: Other items for budget reanalysis FYI, for budget reanalysis discussion on Friday's TC call (excerpt from Rob Schnatter email) ... SHE items being checked by Rob Schnatter, to determine 1) whether they are currently covered on a SHS budget, and 2) if not, which is the most appropriate budget to include item. > "Tom -- Since Rich, Otto and EMBSI (I believe) have requests for additional > funding on the table already, I think that this last request needs to look > at whether there are any gaps in what the three of us have considered. > (Assume that this has also been broached from FU/XiBiao's perspective?) > > I believe there are a few possible areas to consider: > > (a) Additional EA help. I still believe we are short-staffed for > on-the-ground help in Shanghai. In the recent staff meetings that I > attended at Fudan, it seemed that the ME phase1 EA activities slowed > progress for CC/DP EA activities and vice versa. It would be nice to have > two dedicated teams, perhaps with two 'sub-leaders' (under XiBiaolYimei). > This will only get worse when phase 2 starts up again. I thought 3-4 more > persons would be appropriate, but Yimei and XiBiao would be able to assess > this better. I still beleive a 'factory laison' person is needed.. don't > know whether all of this is in Rich's budget request. (Rich?) > > (b) Addtional support from Dr. Ni. He has been excelent in terms of > identifying factories for ME, but there are still issues that need to be > worked with him. One such issue is that medical exams for 'normals' may be > stored in different places than medical exams for 'abnormals'. This needs > to be tested thoroughly. Also, more factories need to be recruited, and it > is my understanding that his contract was finished in March. (Rich to > verify). I belive we need Dr. Ni through 2006. > > (c) As you mention, additional EA 'expert' help. As we seem to be leaning > toward a job/sector (or JEM) approach, additional reviewers such as Jack > Siematycki (who has turned the JEM into a science), Coble, as you mention, > Vermuillen, etc. I appreciate that we have EA skills on the SRP, but more > on the ground review may be needed, especially for the CC/DP study. You > would be the person to decide scope/amount. > > (d) Incentive payments to factory managers, district IPHS offices, etc. SH ELL-MCCLU RG-OS7S94